Outlook Therapeutics, Inc. (OTLK) Total Assets by Year
Outlook Therapeutics, Inc. closed fiscal year 2025 with $18.6M in total assets, $50.8M in total liabilities and -$32.2M in shareholder equity. This represents a decrease of 35.5% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Outlook Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
OTLK Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.6M-35.5% | $28.8M-10.8% | $32.3M+13.2% | $28.5M+25.1% | $22.8M+15.6% | $19.7M+15.2% | $17.1M-23.1% | $22.3M+7.5% | $20.7M-18.4% | $25.4M-27.4% | $35.0M |
| Total Liabilities | $50.8M-50.2% | $101.9M+118.0% | $46.7M+136.2% | $19.8M+8.7% | $18.2M+7.7% | $16.9M-49.2% | $33.3M-30.5% | $47.8M-7.1% | $51.5M+68.3% | $30.6M-65.7% | $89.2M |
| Total Equity | -$32.2M+56.0% | -$73.1M-406.1% | -$14.4M-265.3% | $8.7M+89.6% | $4.6M+63.0% | $2.8M+117.5% | -$16.1M+36.9% | -$25.5M+24.1% | -$33.7M-550.5% | -$5.2M+90.5% | -$54.2M |
OTLK Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.2M+16.9% | $21.9M+14.8% | $18.2M+7.2% | $18.6M-35.5% | $22.4M-52.5% | $19.1M-67.7% | $17.0M-21.6% | $28.8M-10.8% | $47.1M+5.9% | $59.0M+9.3% | $21.7M-65.4% | $32.3M+13.2% |
| Total Liabilities | $36.6M-38.6% | $50.9M-1.3% | $56.8M-15.6% | $50.8M-50.2% | $59.6M-54.4% | $51.5M-73.3% | $67.3M+46.2% | $101.9M+118.0% | $130.8M+161.8% | $193.3M+343.9% | $46.0M-1.9% | $46.7M+136.2% |
| Total Equity | -$10.4M+72.1% | -$29.0M+10.7% | -$38.5M+23.3% | -$32.2M+56.0% | -$37.2M+55.6% | -$32.5M+75.8% | -$50.3M-106.6% | -$73.1M-406.1% | -$83.7M-1420.6% | -$134.2M-1379.9% | -$24.3M-254.5% | -$14.4M-265.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Outlook Therapeutics, Inc. financials
Frequently Asked Questions
What was Outlook Therapeutics, Inc.'s total assets in fiscal year 2025?
Outlook Therapeutics, Inc. closed fiscal year 2025 with $18.6M in total assets, $50.8M in total liabilities and -$32.2M in shareholder equity.
How fast is Outlook Therapeutics, Inc.'s total assets growing?
Outlook Therapeutics, Inc. (OTLK) total assets fell by 35.5% year over year, from $28.8M to $18.6M in fiscal year 2025.
How has Outlook Therapeutics, Inc.'s total assets changed over the years?
Across the 11 fiscal years this page covers, Outlook Therapeutics, Inc. (OTLK) total assets went from $35.0M in fiscal year 2015 to $18.6M in fiscal year 2025.
What was Outlook Therapeutics, Inc.'s total assets in the most recent quarter?
Outlook Therapeutics, Inc. (OTLK) reported $26.2M in total assets in Q3 2026. This represents an increase of 16.9% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Outlook Therapeutics, Inc. (OTLK) reported on that line in every period on record.